News

Pharmabiz7h
Scipher Medicine inks partnership with Kythera Labs to unlock new insights into autoimmune disease-specific treatment
Scipher Medicine inks partnership with Kythera Labs to unlock new insights into autoimmune disease-specific treatment: Waltham, Massachusetts Thursday, April 17, 2025, 17:00 Hrs [ ...
Pharmabiz6h
Meribel Pharma Solutions launches network across Europe to elevate pharma services to new heights
Meribel Pharma Solutions launches network across Europe to elevate pharma services to new heights: United Kingdom Thursday, April 17, 2025, 18:00 Hrs [IST] UK headquartered Meribe ...
Pharmabiz7h
Abbott with IQVIA highlights reality of vertigo in India
Abbott in collaboration with IQVIA highlights that 44% of people have been living with vertigo for more than a year, experiencing episodes once a week. Many mistake vertigo for low blood sugar, low ...
Pharmabiz8h
LUMA Vision receives US FDA clearance for Verafeye 2D/4D cardiac visualization platform
LUMA Vision receives US FDA clearance for Verafeye 2D/4D cardiac visualization platform: Dublin Thursday, April 17, 2025, 16:00 Hrs [IST] LUMA Vision Ltd, an innovative leader in ...
Pharmabiz10h
B. Braun introduces Ezcover Probe Cover Set for improved ultrasound safety in peripheral nerve block procedures
B. Braun introduces Ezcover Probe Cover Set for improved ultrasound safety in peripheral nerve block procedures: Bethlehem, Pennsylvania Thursday, April 17, 2025, 14:00 Hrs [IST] ...
Pharmabiz9h
ImmunityBio announces US FDA submissions of sBLA for NMIBC papillary disease and EAP for Anktiva to treat lymphopenia
ImmunityBio announces US FDA submissions of sBLA for NMIBC papillary disease and EAP for Anktiva to treat lymphopenia: Culver City, Calif Thursday, April 17, 2025, 15:00 Hrs [IST] ...
Pharmabiz12h
Atsena Therapeutics receives US FDA’s RMAT designation for ATSN-201 gene therapy to treat X-linked Retinoschisis
Durham, North Carolina Thursday, April 17, 2025, 12:00 Hrs [IST] ...
Pharmabiz11h
Belhaven Biopharma announces promising study results from its dose confirmational clinical trial of Nasdepi
Belhaven Biopharma announces promising study results from its dose confirmational clinical trial of Nasdepi: Raleigh, North Carolina Thursday, April 17, 2025, 13:00 Hrs [IST] Belh ...
Pharmabiz8h
Sterling Accuris strengthens presence in diagnostics through acquisition of Gujarat Pathology Laboratory and Diagnostic Centre
Sterling Accuris strengthens presence in diagnostics through acquisition of Gujarat Pathology Laboratory and Diagnostic Centre: Our Bureau, Mumbai Thursday, April 17, 2025, 15:45 ...
Pharmabiz13h
QIAGEN to launch three new sample preparation instruments by 2026 to improve lab automation
QIAGEN to launch three new sample preparation instruments by 2026 to improve lab automation: Venlo, Netherlands Thursday, April 17, 2025, 11:00 Hrs [IST] QIAGEN, leading global pr ...
Pharmabiz11h
Venus Remedies’ novel polymyxin B formulation, VRP-034 gets US FDA QIDP designation
Venus Remedies’ novel polymyxin B formulation, VRP-034 gets US FDA QIDP designation: Our Bureau, Bengaluru Thursday, April 17, 2025, 12:15 Hrs [IST] Venus Remedies’ investigat ...
Pharmabiz14h
Study led by Karl Landsteiner University of Health Sciences reveals blind spots in India’s digital health landscape
Study led by Karl Landsteiner University of Health Sciences reveals blind spots in India’s digital health landscape: Krems, Austria Thursday, April 17, 2025, 10:00 Hrs [IST] Sma ...